Evidence map›Paper›PMID 37438746›Full record

ArticleJournal of biomedical science2023

Correction: Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling.

Sheng-Chieh Lin, Yi-Chu Liao, Po-Ming Chen, Ya-Yu Yang, Yi-Hsiang Wang, Shiao-Lin Tung, Chi-Mu Chuang, Yu-Wen Sung, Te-Hsuan Jang, Shuang-En Chuang and 1 more

Open access · diamondAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of biomedical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Sheng-Chieh Lin *Graduate Institute of Integrated Medicine and Chinese Medicine Research Center, China Medical University, No. 91, Hsueh Shih Road, Taichung, 40402, Taiwan.
Yi-Chu Liao *Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Po-Ming Chen *Graduate Institute of Integrated Medicine and Chinese Medicine Research Center, China Medical University, No. 91, Hsueh Shih Road, Taichung, 40402, Taiwan.
Ya-Yu YangNational Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.
Yi-Hsiang WangInstitute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Shiao-Lin TungDepartment of Hematology and Oncology, Ton-Yen General Hospital, Hsinchu, Taiwan.
Chi-Mu ChuangDepartment of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan.
Yu-Wen SungGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Te-Hsuan JangNational Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.
Shuang-En ChuangNational Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.
Lu-Hai WangGraduate Institute of Integrated Medicine and Chinese Medicine Research Center, China Medical University, No. 91, Hsueh Shih Road, Taichung, 40402, Taiwan. luhaiwang@mail.cmu.edu.tw.ORCID http://orcid.org/0000-0003-0050-8560
National Health Research Institutes · TWChina Medical University · TWHsin Sheng College of Medical Care and Management · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37438746
PMCPMC10337140
OpenAlexW4384067909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.